Renovaro Biosciences (RENB) Accounts Payable

Annual Accounts Payable

$9.45 M
+$4.15 M+78.39%

June 30, 2024


Summary


Performance

RENB Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRENBbalance sheetmetrics:

Quarterly Accounts Payable

$10.93 M
-$467.60 K-4.10%

December 31, 2024


Summary


Performance

RENB Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRENBbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

RENB Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+78.4%+15.7%
3 y3 years+2847.2%+15.7%
5 y5 years+1654.3%+15.7%

RENB Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+2847.2%-4.1%+6455.5%
5 y5-yearat high+2847.2%-4.1%+6455.5%
alltimeall timeat high+2847.2%-4.1%>+9999.0%

Renovaro Biosciences Accounts Payable History

DateAnnualQuarterly
Dec 2024
-
$10.93 M(-4.1%)
Sep 2024
-
$11.40 M(+20.7%)
Jun 2024
$9.45 M(+78.4%)
$9.45 M(+18.2%)
Mar 2024
-
$7.99 M(+43.3%)
Dec 2023
-
$5.58 M(+2.9%)
Sep 2023
-
$5.42 M(+2.3%)
Jun 2023
$5.30 M(+277.8%)
-
Jun 2023
-
$5.30 M(+18.5%)
Mar 2023
-
$4.47 M(-1.8%)
Dec 2022
-
$4.56 M(-2.7%)
Sep 2022
-
$4.68 M(+234.0%)
Jun 2022
$1.40 M(+337.3%)
$1.40 M(+187.9%)
Mar 2022
-
$487.00 K(+192.0%)
Dec 2021
-
$166.80 K(-69.6%)
Sep 2021
-
$547.90 K(+70.9%)
Jun 2021
$320.60 K(-45.9%)
$320.60 K(-36.5%)
Mar 2021
-
$504.90 K(+167.3%)
Dec 2020
-
$188.90 K(-33.1%)
Sep 2020
-
$282.40 K(-52.4%)
Jun 2020
$592.90 K(+10.1%)
$592.90 K(+80.5%)
Mar 2020
-
$328.40 K(-47.7%)
Dec 2019
-
$628.00 K(+3.0%)
Sep 2019
-
$609.60 K(+13.2%)
DateAnnualQuarterly
Jun 2019
$538.60 K(-5.8%)
$538.60 K(-57.6%)
Mar 2019
-
$1.27 M(+68.5%)
Dec 2018
-
$753.90 K(+5.7%)
Sep 2018
-
$713.10 K(+24.7%)
Jun 2018
$571.80 K(-14.7%)
$571.80 K(-36.4%)
Mar 2018
-
$898.60 K(-3.8%)
Dec 2017
-
$933.80 K(+109.9%)
Sep 2017
-
$444.90 K(-33.6%)
Jun 2017
$670.00 K(-43.5%)
$670.00 K(-45.5%)
Mar 2017
-
$1.23 M(+15.4%)
Dec 2016
-
$1.06 M(-1.1%)
Sep 2016
-
$1.08 M(-9.1%)
Jun 2016
$1.19 M(+34.9%)
$1.19 M(+49.1%)
Mar 2016
-
$794.70 K(+27.5%)
Dec 2015
-
$623.20 K(-30.2%)
Sep 2015
-
$893.20 K(+8.5%)
Jun 2015
$878.80 K(-4.9%)
-
Mar 2015
-
$823.00 K(-10.9%)
Dec 2014
$923.90 K
$923.90 K(+48.1%)
Sep 2014
-
$624.00 K(-6.7%)
Jun 2014
-
$668.90 K(+17.7%)
Mar 2014
-
$568.20 K(>+9900.0%)
Dec 2011
-
$400.00

FAQ

  • What is Renovaro Biosciences annual accounts payable?
  • What is the all time high annual accounts payable for Renovaro Biosciences?
  • What is Renovaro Biosciences annual accounts payable year-on-year change?
  • What is Renovaro Biosciences quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Renovaro Biosciences?
  • What is Renovaro Biosciences quarterly accounts payable year-on-year change?

What is Renovaro Biosciences annual accounts payable?

The current annual accounts payable of RENB is $9.45 M

What is the all time high annual accounts payable for Renovaro Biosciences?

Renovaro Biosciences all-time high annual accounts payable is $9.45 M

What is Renovaro Biosciences annual accounts payable year-on-year change?

Over the past year, RENB annual accounts payable has changed by +$4.15 M (+78.39%)

What is Renovaro Biosciences quarterly accounts payable?

The current quarterly accounts payable of RENB is $10.93 M

What is the all time high quarterly accounts payable for Renovaro Biosciences?

Renovaro Biosciences all-time high quarterly accounts payable is $11.40 M

What is Renovaro Biosciences quarterly accounts payable year-on-year change?

Over the past year, RENB quarterly accounts payable has changed by +$1.49 M (+15.73%)